Using Trademarks to Ensure Completion of Postapproval Trials
This Viewpoint evaluates how using trademarks can support the US Food and Drug Administration’s mission to approve safe and effective medications.
Authors
- Catherine S. Hwang (ORCID: https://orcid.org/0009-0004-0185-3256)
- S. Sean Tu (ORCID: https://orcid.org/0000-0003-0391-8186)
Institutions
- West Virginia University (US)
- Oregon Health & Science University (US)
- VA Portland Health Care System (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.0001
- Citations
- 2
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 2.33